Impact of Existing and Emerging Global Interventional Cardiology Market Trends And Forecast 2020-2027

 Interventional Cardiology Market Forecast

Global Interventional Cardiology Market held a value of USD 15,130.75 Million in 2018 and is expected to register a CAGR of 7.25% during the assessment period of 2019 to 2025.

Interventional Cardiology Market Synopsis

Interventional cardiology deals with the catheter-based treatment of heart diseases. Scrutinizing all the global territories, it has been noticed that there is a huge rise in the number of cardiac diseases. This can be attributed to the change in lifestyle, leading to lifestyle diseases. Each year cardiovascular diseases cause 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU).

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8735 

In addition to that, the rise in the number of clinical trials of devices for use in interventional cardiology procedures is set to propel the growth of the market. For instance, in August 2018, B. Braun Melsungen AG announced that its drug-coated balloon ‘SeQuent Please’ for percutaneous transluminal coronary angioplasty showed positive results in the BASKET-SMALL 2 clinical trial. Moreover, the trend of bioresorbable stents going to contribute substantially to the growth of the market. For instance, in February 2019, Biotronik was granted approval from the FDA for its a drug-eluting stent system which is ultrathin and bioabsorbable for the treatment of patients with coronary artery disease.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas held maximum share in the base year 2018, owing to the high incidence rates of cardiac disorders and strategic activities by major players in countries such as the US. The interventional cardiology market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European interventional cardiology market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The European market for interventional cardiology is expected to hold a substantial Interventional Cardiology Market share owing to the increase in the number of cardiac disorder cases. For instance, in 2016, there were 66,076 deaths due to coronary heart diseases in the UK, which was the third-highest cause of death in that particular year. The interventional cardiology market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The interventional cardiology market in this region is anticipated to be the fastest-growing during the forecast period due to the increasing uptake and adoption rate of newer treatment options by patients as well as medical professionals. The increasing patient pool and mortality rate due to cardiac diseases in these countries also fuel the market growth. For instance, in 2017, ischemic heart disease was the second-highest cause for death in Japan. The interventional cardiology market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Interventional Cardiology Market has been segmented based on Type, and End User.

The market, based on type, has been segmented into stents, percutaneous transluminal coronary angioplasty (PTCA) catheters, plaque modification devices, coronary guidewires, and accessories. The market, based on stents, has been further divided into drug-eluting stents, bare-metal stents, and bioresorbable vascular scaffolds. The stents segment held a major share in 2018 owing to the increased number of product launches by key players in the current years. This segment is also expected to be the fastest-growing segment during the forecast period due to the increasing prevalence of coronary artery disease, and continued innovations by players. The market, based on PTCA catheters, has been segmented into balloon catheters, and guiding catheters.

The Global Interventional Cardiology Market has been segmented, based on end-user, into hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and others. In 2018, the hospital's segment held the majority share of the market owing to the increasing number of patient admissions due to coronary diseases. The cardiac catheterization laboratory segment is projected to be the fastest-growing segment owing to the increasing preference of cath labs by medical professionals.

Key Players

Some of the Key Players in the Global Interventional Cardiology Market are ABIOMED (US), Abbott (US), ACIST Medical Systems, Inc. (the US), B. Braun Melsungen AG (Germany), BD (US), Biosense Webster, Inc (US), Biotronik SE & Co. KG (Germany), Boston Scientific Corporation (US), Cardinal Health (US), Cook Medical (US), Edwards Lifesciences Corporation (US), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Life Vascular Devices Biotech S.L. (Spain), Medtronic (Ireland), Merit Medical Systems, Inc (US), Terumo Corporation (Japan), and W. L. Gore & Associates, Inc. (US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/interventional-cardiology-market-8735 

 

Global Microtome Market to Witness Steady Growth through 2027

 Microtome Market accounted for USD 120 Million in 2018 at a CAGR of 6.1%.

Market Synopsis

A microtome is a tool used to cut extremely thin sections of tissue samples of plants or animals. Microtomes help in extremely fine cuts that are important for preparations used in microscopy. The high preference of microtome in cancer biopsy will drive the growth positively over the forecast period due to rising cases of cancer worldwide.  According to WHO, around 18.1 million new cases of cancer were diagnosed in 2018.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8568

Key Players

Some of the key players in the Global Microtome Market share are Amos Scientific Pty Ltd (Australia), Danaher (US), Diapath S.p.A. (Italy), Histo-Line Laboratories (Italy), Jinhua YIDI Medical Appliance Co., Ltd (China), MEDITE GmbH (Germany), Boeckeler Instruments, Inc. (US), Sakura Finetek (Japan), SLEE Medical GmbH (Germany), and Thermo Fisher Scientific (US)

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The microtome market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European microtome market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The microtome market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing prevalence of chronic disorders and increasing patient pool, the market in Asia-Pacific is expected to be the fastest-growing. The microtome market in the Middle East & Africa has been bifurcated into the Middle East and Africa.

Segmentation

The Global Microtome Market has been segmented based on product, application, technology, and end-user.

The market, based on product, has been divided into instruments and accessories. Instruments are further sub-segmented into rotary microtomes, cryostat microtomes, vibrating microtomes, and others. Instruments are expected to hold the largest share, due to the commercial availability of these systems and their high adoption rate due to ease of handling.

In terms of application, the global microtome market has been segmented into disease diagnosis and medical research. Disease diagnosis takes up the largest share due to the increasing number of tissue examinations in research laboratories and hospitals owing to rising awareness about the benefits of early diagnosis of diseases like cancer.

In terms of technology, the global microtome market has been segmented into manual, semi-automated microtomes, and fully automated microtomes. The fully automated segment held the majority share due to rising demand for technologically advanced products and its ability to show the highest precision in section thickness. Additionally, fully automated microtomes do not require tedious manual adjustments.

In terms of end-user, the global microtome market has been segmented into hospital laboratories and clinical laboratories. Hospital laboratories take up the largest share. The positive growth of hospitals is attributed to factors such as a high volume of routine tissue examinations performed in hospital-based laboratories across the globe and growing patient population.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/microtome-market-8568 

 

Cell Lysis and Disruption Market Excessive Growth Opportunities Estimated to be Experienced 2020-2027

 Global Cell Lysis & Disruption Market size is expected to cross USD 5.7 Billion by 2025 at a CAGR of 8.6%.

Market Synopsis

Cell lysis & disruption is a method in which the cell membrane is broken down in order to extract the nucleic acids or proteins from a cell. The choice of cell lysis method depends on the type of cells, concentration, application (post-processing) and efficiency required. The demand for cell lysis & disruption is increasing due to the rising number of research & development activities in the biotechnology industry. This is majorly attributed to the increasing adoption of biotech processes in the pharmaceutical, agricultural sector.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8358 

Market Influencers

The rising focus on personalized medicine would directly drive the growth of the global cell lysis & disruption market. Strategic initiatives, mergers & acquisitions, partnerships, agreements, product launches, government approvals, and expansion of manufacturing facilities by major competitors are expected to positively affect market growth during the forecast period.   

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global cell lysis & disruption market owing to the growing clinical R&D budgets by both governments as well as public and private organizations in the pharmaceutical and biotech sector and increasing demand for novel therapeutics in the region.  Additionally, the rising prevalence of geriatric population along with various chronic diseases is contributing to the growth of this market. According to a report by the Population Reference Bureau, the number of older population (aged 65 and above) will rise to nearly 24% from 15% by 2060. Europe is expected to hold the second-largest position in the global cell lysis & disruption market owing to the presence of a strong academic & research base and availability of funding for research in the European countries. Moreover, rising healthcare expenditure is boosting the market in this region. Asia-Pacific is anticipated to be the fastest-growing region is due to the growing interest of major key players in emerging markets and rapidly developing healthcare infrastructure in this region. The Middle East & Africa has the least share of the global cell lysis & disruption market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.  

Segmentation

The global cell lysis & disruption market has been segmented into technique, product, cell type, and end user.

By technique, the market has been segregated into reagent based and physical disruption. The reagent based segment has been further sub-segmented into detergent and enzymatic. The physical disruption further divided into mechanical homogenization, ultrasonic homogenization, pressure homogenization, and temperature treatments

By product, the market has been bifurcated into consumables and instruments. The consumables segment is estimated to hold major market share in the market due to the rise in funding of cell based research. Consumables has been further divided into reagent and kits, beads and disposables. The instrument segment has been further categorized as sonicators, homogenizers, French press, microfluidizer, and others.  

On the basis of cell type, the global cell lysis & disruption market has been classified as mammalian cells, microbial cells, and others.

The global cell lysis & disruption market, by end user, has been divided into research laboratories and institutes, pharmaceutical and biotechnology companies, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cell-lysis-disruption-market-8358 

 

Radiology Services Market – Functional Survey 2027

 The global radiology services market accounted for USD 8,102.51 million in 2018 and is expected to register a CAGR of 10.5% during the forecast period (2019–2024).

Radiology is the technology that diagnosis and treat diseases within the human body by using medical imaging. The radiology services are served by the radiologists and experts that are qualified for performing the test and have unique postgraduate medical education in, radiation effects on the human body, radiation safety/protection, appropriate performance and interpretation of quality radiologic, and medical imaging examinations. Radiology services comprise X-Rays, computed tomography (CT), ultrasound, fusion imaging, positron emission tomography (PET), nuclear medicine, and magnetic resonance imaging (MRI). These imaging techniques should be performed after having adequate training and understanding of radiation safety and protection.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7904 

The rising prevalence of the chronic disease, increasing healthcare expenditure, the emergence of thin client 3D viewers, advancement in radiology technology, rising demand for minimally invasive procedures are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, In June 2018, FDA has anticipated reclassifying some types of radiology image software analyzers from class III to class II devices for mammography breast cancer, ultrasound breast lesions, and radiograph lung nodules. This will help to reduce the regulatory burden on the medical device industry.

However, the risk of high radiation exposure associated with the devices may hamper the growth of the market during the assessment period.

Segmentation

The global radiology services industry has been segmented on the basis of product type, application, technology, end user, and region.

On the basis of the product type, the market has been segmented into stationary digital radiology systems and portable digital radiology systems. stationary digital radiology systems have been further segmented into stationary ceiling-mounted systems and floor-to-ceiling mounted system. On the basis of the application, the market has been classified into cardiovascular imaging, chest imaging, dental imaging, mammography imaging, orthopedic imaging, and others. Based on the technology, the market has been segmented into computed radiology and direct digital radiology. On the basis of the end user, the market has been classified as hospitals, diagnostic centers, and others. The stationary digital radiology segment is likely to hold the noticeable market share of the radiology services market due to the rising demand for stationary systems in hospitals, wide application, and less radiation exposure. However, portable digital radiology segment is showing the highest growth rate during the assessment period owing to simplicity in workflow, low-cost, and proficiency performing complex computational tasks.

Key Players

Some of the prominent key players in the global radiology services market are 4ways Healthcare Limited, Cybernet Medical Corporation, Everlight Radiology, Global Diagnostics, Medica Reporting Ltd., Onrad, Inc, Radisphere National Radiology Group Inc., RamSoft Inc., Siemens Healthcare, Telediagnostics Services Pvt. Ltd., Telemedicine Clinic, Teleradiology Solutions Inc, and Virtual Radiology (vRAD).

Regional Analysis

The market is likely to dominate by Americas during the forecast period owing to the increasing aging population, chronic disease, funding & investments, and government initiative towards advance healthcare infrastructure. The European market is expected to be the second-largest due to government funding and support of the healthcare sector coupled with increasing research and development, and favorable reimbursement policies. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing prevalence of cancer, rising investments in healthcare, and expansions by market players in the region. The market in the Middle East & Africa is likely to account for the smallest share of the global radiology services market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/radiology-services-market-7904 

 

Healthcare Analytics Market Current Trends, SWOT Analysis, Strategies, Industry Challenges, Business Overview and Forecast Research Study 2027

 Global healthcare analytics market size is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 12,126.70 million in 2018 and is projected to grow at a CAGR of 27.1% over the forecast period. Healthcare analytics is one of the major segment of analysis that primarily focuses on providing insights into hospital management, costs, patient records, diagnoses, and various other data. The field covers all the segments of the healthcare industry, providing insights on both the macro and micro level. The global healthcare/medical analytics market growth is expected to grow at a rapid pace due to factors such as high adoption of technological advancements in the field of healthcare, increasing demand for reducing paperwork, better treatment plans in collaboration with pharmaceutical organizations, increasing availability of low cost technology, to improve patient care efforts, better services, and improve existing procedures.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7819 

For improve, treatment plans in association with pharmaceutical organizations are one of the major factors for analytics-driven revolution in healthcare. With more access to wide and in-depth information, pharmaceutical organizations can come up with better formulations for diseases. With the help of more data and analytics, pharmaceutical organizations will be able to assure their formulations positively. This will eventually move the trend from volume discounts to evidence-based outcome models. However, with these advantages of healthcare analytics driving the growth of the market, few restraints are hampering the growth of the market including; data security, high cost of analytical solutions, and technology challenged the user.   

Regional Analysis

Geographically the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Geographically, the Americas is anticipated to dominate the global healthcare analytics market owing to presence of well-established players in the, well-established penetration of information technology in the field of healthcare, for instance, according to reports by the Centers for Disease Control and Prevention in 2017, approximately 86.9% of the hospital-based physicians used the EMR/EHR system. This growing inclination towards healthcare IT to offer efficient care and rising government initiatives would fuel upmarket growth during the forecast period. However, the Asia-Pacific region is expected to grow at the fastest growth rate. The major factors influencing the growth of the in the region include; increasing need to reduce medical errors is driving the growth of the healthcare analytics market. An increasing number of new vendors involved in healthcare analytics is also expected to drive the growth of the market over the forecast period. 

Segmentation

The global healthcare analytics market has been segmented into type, component, delivery model, application, and end user.

Based on type, market segmented into descriptive analytics, predictive analytics, prescriptive analytics, and cognitive analytics.

Based on component, market segmented into software, hardware, and services.

Based on delivery mode, market segmented into on-premise and on-demand.

Based on application, the healthcare analytics market is segmented into Financial Analytics (Claims Processing, Revenue Cycle Management (RCM), Payment Integrity & Fraud, Waste, and Abuse (FWA), Risk Adjustment & Assessment), Clinical Analytics (Quality Improvement & Clinical Benchmarking, Clinical Decision Support (CDS)), operational & administrative analytics, population health analytics

Based on end user, healthcare analytics market segmented into Payers (Private Insurance Companies, Government Agencies, Employers and Private Exchanges), Providers (Hospitals & Clinics, Post-Acute Care Organizations, Ambulatory Settings), and others.

Key Players

Some of the major players operating in the global healthcare analytics market are SAS Institute Inc., Cerner, Allscripts Healthcare Solutions, Citiustech, Health Catalyst, McKesson, Optum, Oracle, IBM, SCIO Health Analytics, Vitreoshealth, Wipro, Inovalon, Cotiviti, Medeanalytics, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-analytics-market-7819 

 

Veterinary Infusion Pumps Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

 The upcoming Global veterinary infusion pumps market trends expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 85.9 million in 2017 and is projected to grow at a CAGR of 4.9% over the forecast period.

The factors such as growing demand for pet insurance and increasing animal healthcare expenditure, rising demand for animal-derived food products, and growth in the number of veterinary practitioners and their income levels are expected to propel the growth of the market. However, increasing animal care costs hamper the market growth over the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7417 

Regional Analysis

Geographically, the Americas is expected to dominate the global veterinary infusion pumps market owing to the presence of well-established players, increasing demand for pet insurance and increasing animal healthcare expenditure, rising demand for animal-derived food products, growth in the number of veterinary practitioners and their income levels, and increasing prevalence of animal diseases. Europe is expected to hold the second largest position in the global veterinary infusion pumps market. Asia-Pacific is expected to be the fastest growing market owing to the increasing prevalence of animal diseases. Furthermore, the Middle East and Africa region is expected to account for the least market share in the global veterinary infusion pumps market.

Segmentation

The global veterinary infusion pumps market has been segmented into type, end user, and region.

Based on type, veterinary infusion pumps market is segmented into syringe infusion pump and large-volume infusion pump. The large-volume infusion pump segment is expected to account for the largest share segment of the veterinary infusion pumps market in 2017.

Based on end user, veterinary infusion pumps market is segmented into veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment expected to account for the largest share segment of the veterinary infusion pumps market in 2017.

Key Players

Some of the prominent players in the global veterinary infusion pumps market are Vetland Medical Sales & Services LLC (US), Jørgen Kruuse A/S (Denmark), Heska Corporation (US), B. Braun Melsungen AG (Germany), Burtons Medical Equipment Ltd (UK), Q Core Medical Ltd (Israel), DRE Veterinary (US), SAI Infusion Technologies (US), Grady Medical Systems (US), and Leading Edge Veterinary Equipment, Inc. (US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/veterinary-infusion-pumps-market-7417 

 

Impact of Existing and Emerging Global Catheter Stabilization Device Market Trends And Forecast 2020-2027

 Global Catheter Stabilization Device Market is expected to register a CAGR of 7.1% during the forecast period of 2018 to 2023.Catheter stabilization device are the new standard of excellence for suture-free stabilization of biliary and nephrostomy percutaneous drainage, and peritoneal lavage catheters. These devices are used to secure catheters and infusion or drainage devices and to facilitate their operations. Furthermore, growing prevalence of cardiovascular diseases is driving the growth of the market. According to the World Health Organization in 2017, cardiovascular diseases were the main cause of the deaths across the global. It was estimated that in 2015, approximately 17.7 million people died from cardiovascular diseases, repressing 31% of all the global deaths. Of these deaths, an estimated 7.4 million were due to the coronary heart diseases and 6.7 million were due to stroke. Moreover in 2017, according to the American Heart Association, 801,000 deaths in the U.S. were accounted for the cardiovascular diseases. Moreover, the global cost for cardiovascular diseases is estimated to reach USD 1044 billion by 2030 from USD 863 billion in 2010.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6944 

Segmentation:

The Global Catheter Stabilization Devices Market is segmented based on product type, application, end user, and region.On the basis of product type, the market is segmented into Arterial Securement Devices, Central Venous Catheter Securement Devices (further sub segmented into PICC Securement Devices, Subclavian Securement Devices, Midlines Securement Devices, Femoral Securement Devices, Portal Securement Devices, Jugular Securement Devices) Peripheral Securement Devices (further sub segmented into Foley Catheter Securement Devices, Nasogastric Tubes Securement Devices,  Endotracheal Tube Securement Devices, Ventriculoperitoneal Securement Devices, Continuous Nerve Block Catheter Securement Devices) Chest Drainage Tube Securement Devices, Abdominal Drainage Tubes Securement Devices (further sub segmented into Percutaneous Endoscopic Gastrostomy Securement Devices, Jejunal Catheter Securement Devices, Umbilical Catheter Securement Devices)Epidural Securement Devices. Further, on the basis of application the market is segmented into Cardiovascular Procedures, Respiratory Procedures, Gastric and Oropharyngeal Procedures, General Surgery, Urological Procedures, Radiology and Others. End users is segmented into Hospitals & Clinics, Home Healthcare Providers and Diagnostic Centers.

Regional Analysis:

The Global Catheter Stabilization Devices Market is segmented on the basis of regions: Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas accounted for the major share of the market owing to the huge patient population, well-developed technology, and high healthcare expenditure. Asia Pacific accounted for the second largest market, which is followed by Europe. Asia Pacific is the fastest growing catheter stabilization devices market owing to rapidly changing healthcare sector, huge patient pool in this region, and the presence of vast opportunities for the development of this market. Increasing government support for research & development, well-developed healthcare infrastructure, and presence of geriatric population have driven the European catheter stabilization devices market. However, the Middle East & Africa has the least share in the market owing to the presence of poor and slow developing countries, especially, in African region. The Middle East held the major share of the regional market due to well-developed infrastructure and high spending.

Key players

Some of the key players in the global catheter stabilization market are 3M Company, B. Braun Melsungen Ag, Baxter International, Inc., C. R. Bard, Inc., Centurion Medical Products, Convatec, Inc M.C. Johnson Company, Inc, Medtronic PLC, Merit Medical Systems, Inc, Smiths Group PLC, TIDI Products, LLC and others

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/catheter-stabilization-market-6944